UcarMMjorndalTDahlqvistR. HMG-CoA reductase inhibitors and myotoxicity. Drug Saf2000; 6: 441–57.
2.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEA. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.
3.
De PinieuxGChariotPAmmi-SaïdMLouarnFLejoncFLAstierA. Lipid-lowering drugs and mitochondrial function: Effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br J Clin Pharmacol1996; 42: 333–7.
4.
AldrichTKPrezantDJ. Adverse effect of drugs on the respiratory muscles. Clin Chest Med1990; 1: 177–89.
5.
SugiyamaS. HMG CoA reductase inhibitor accelerates aging effect on diaphragm mitochondrial respiratory function in rats. Biochem Mol Biol Int1998; 5: 923–31.
